National strategy for palliative care of severely ill and dying people and their relatives in pandemics (PallPan) in Germany - study protocol of a mixed-methods project.

End of life care Palliative care Pandemic Pandemic preparedness SARS-CoV-2

Journal

BMC palliative care
ISSN: 1472-684X
Titre abrégé: BMC Palliat Care
Pays: England
ID NLM: 101088685

Informations de publication

Date de publication:
13 Jan 2022
Historique:
received: 11 03 2021
accepted: 17 12 2021
entrez: 14 1 2022
pubmed: 15 1 2022
medline: 18 1 2022
Statut: epublish

Résumé

In the SARS-CoV-2 pandemic, general and specialist Palliative Care (PC) plays an essential role in health care, contributing to symptom control, psycho-social support, and providing support in complex decision making. Numbers of COVID-19 related deaths have recently increased demanding more palliative care input. Also, the pandemic impacts on palliative care for non-COVID-19 patients. Strategies on the care for seriously ill and dying people in pandemic times are lacking. Therefore, the program 'Palliative care in Pandemics' (PallPan) aims to develop and consent a national pandemic plan for the care of seriously ill and dying adults and their informal carers in pandemics including (a) guidance for generalist and specialist palliative care of patients with and without SARS-CoV-2 infections on the micro, meso and macro level, (b) collection and development of information material for an online platform, and (c) identification of variables and research questions on palliative care in pandemics for the national pandemic cohort network (NAPKON). Mixed-methods project including ten work packages conducting (online) surveys and qualitative interviews to explore and describe i) experiences and burden of patients (with/without SARS-CoV-2 infection) and their relatives, ii) experiences, challenges and potential solutions of health care professionals, stakeholders and decision makers during the SARS-CoV-2 pandemic. The work package results inform the development of a consensus-based guidance. In addition, best practice examples and relevant literature will be collected and variables for data collection identified. For a future "pandemic preparedness" national and international recommendations and concepts for the care of severely ill and dying people are necessary considering both generalist and specialist palliative care in the home care and inpatient setting.

Sections du résumé

BACKGROUND BACKGROUND
In the SARS-CoV-2 pandemic, general and specialist Palliative Care (PC) plays an essential role in health care, contributing to symptom control, psycho-social support, and providing support in complex decision making. Numbers of COVID-19 related deaths have recently increased demanding more palliative care input. Also, the pandemic impacts on palliative care for non-COVID-19 patients. Strategies on the care for seriously ill and dying people in pandemic times are lacking. Therefore, the program 'Palliative care in Pandemics' (PallPan) aims to develop and consent a national pandemic plan for the care of seriously ill and dying adults and their informal carers in pandemics including (a) guidance for generalist and specialist palliative care of patients with and without SARS-CoV-2 infections on the micro, meso and macro level, (b) collection and development of information material for an online platform, and (c) identification of variables and research questions on palliative care in pandemics for the national pandemic cohort network (NAPKON).
METHODS METHODS
Mixed-methods project including ten work packages conducting (online) surveys and qualitative interviews to explore and describe i) experiences and burden of patients (with/without SARS-CoV-2 infection) and their relatives, ii) experiences, challenges and potential solutions of health care professionals, stakeholders and decision makers during the SARS-CoV-2 pandemic. The work package results inform the development of a consensus-based guidance. In addition, best practice examples and relevant literature will be collected and variables for data collection identified.
DISCUSSION CONCLUSIONS
For a future "pandemic preparedness" national and international recommendations and concepts for the care of severely ill and dying people are necessary considering both generalist and specialist palliative care in the home care and inpatient setting.

Identifiants

pubmed: 35027041
doi: 10.1186/s12904-021-00898-w
pii: 10.1186/s12904-021-00898-w
pmc: PMC8756412
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

10

Subventions

Organisme : German Ministry for Education and Research
ID : Förderkennzeichen 01KX2021

Informations de copyright

© 2022. The Author(s).

Références

J Pain Symptom Manage. 2020 Aug;60(2):e81-e86
pubmed: 32376262
Front Psychiatry. 2020 May 26;11:489
pubmed: 32574243
Health Qual Life Outcomes. 2020 Sep 22;18(1):311
pubmed: 32962706
J Pain Symptom Manage. 2020 Sep;60(3):e17-e21
pubmed: 32544647
Psychooncology. 2005 Apr;14(4):262-73
pubmed: 15386769
Pneumologie. 2020 Oct;74(10):652-659
pubmed: 32316056
Omega (Westport). 2021 Feb;82(3):500-522
pubmed: 33086903
J Pain Symptom Manage. 2020 Aug;60(2):e48-e51
pubmed: 32387575
Schmerz. 2020 Aug;34(4):303-313
pubmed: 32488422
Palliat Med. 2020 Jul;34(7):889-895
pubmed: 32348711
Lancet. 2020 May 9;395(10235):1467-1469
pubmed: 32333842
J Pain Symptom Manage. 2020 Jul;60(1):e31-e40
pubmed: 32278097
J Pers Soc Psychol. 1988 Jun;54(6):1063-70
pubmed: 3397865
BMJ Support Palliat Care. 2014 Jun;4(2):167-174
pubmed: 24681559
Lancet. 2017 Apr 15;389(10078):1498-1499
pubmed: 28422014
J Pain Symptom Manage. 2020 Jul;60(1):e77-e81
pubmed: 32325167
Eur Respir J. 2020 Apr 23;55(4):
pubmed: 32269090
Lancet. 2018 Apr 7;391(10128):1391-1454
pubmed: 29032993

Auteurs

C Bausewein (C)

Department of Palliative Medicine, Ludwig-Maximilians-University Munich, Munich University Hospital, Munich, Germany. Claudia.bausewein@med.uni-muenchen.de.

F Hodiamont (F)

Department of Palliative Medicine, Ludwig-Maximilians-University Munich, Munich University Hospital, Munich, Germany.

N Berges (N)

Department of Palliative Medicine, Ludwig-Maximilians-University Munich, Munich University Hospital, Munich, Germany.

A Ullrich (A)

Palliative Care Unit, Department of Oncology, Hematology and Bone Marrow Transplant, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

C Gerlach (C)

Palliative Care Unit, Department of Oncology, Hematology and Bone Marrow Transplant, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

K Oechsle (K)

Palliative Care Unit, Department of Oncology, Hematology and Bone Marrow Transplant, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

B Pauli (B)

Department of Palliative Medicine, University of Cologne, Faculty of Medicine and University Hospital, Cologne, Germany.

J Weber (J)

Hannover Medical School, Institute for General Practice and Palliative Medicine, Palliative Care Reserch Grouph Group, Hannover, Germany.

S Stiel (S)

Hannover Medical School, Institute for General Practice and Palliative Medicine, Palliative Care Reserch Grouph Group, Hannover, Germany.

N Schneider (N)

Hannover Medical School, Institute for General Practice and Palliative Medicine, Palliative Care Reserch Grouph Group, Hannover, Germany.

N Krumm (N)

Department of Palliative Medicine, University Hospital Aachen, Aachen, Germany.

R Rolke (R)

Department of Palliative Medicine, University Hospital Aachen, Aachen, Germany.

C Gebel (C)

Department of Palliative Medicine, Jena University Hospital, Jena, Germany.

M Jansky (M)

Department for Palliative Medicine, Georg August University Goettingen, University Medical Center, Goettingen, Germany.

F Nauck (F)

Department for Palliative Medicine, Georg August University Goettingen, University Medical Center, Goettingen, Germany.

U Wedding (U)

Department of Palliative Medicine, Jena University Hospital, Jena, Germany.

B van Oorschot (B)

Interdisciplinary Centre for Palliative Medicine, University Wuerzburg, University Hospital, Wuerzburg, Germany.

C Roch (C)

Interdisciplinary Centre for Palliative Medicine, University Wuerzburg, University Hospital, Wuerzburg, Germany.

L Werner (L)

Interdisciplinary Centre for Palliative Medicine, University Wuerzburg, University Hospital, Wuerzburg, Germany.

M Fischer (M)

Interdisciplinary Centre for Palliative Medicine, University Wuerzburg, University Hospital, Wuerzburg, Germany.

M Schallenburger (M)

Interdisciplinary Centre for Palliative Care, Heinrich Heine University Duesseldorf, University Hospital, Duesseldorf, Germany.

M C Reuters (MC)

Interdisciplinary Centre for Palliative Care, Heinrich Heine University Duesseldorf, University Hospital, Duesseldorf, Germany.

J Schwartz (J)

Interdisciplinary Centre for Palliative Care, Heinrich Heine University Duesseldorf, University Hospital, Duesseldorf, Germany.

M Neukirchen (M)

Interdisciplinary Centre for Palliative Care, Heinrich Heine University Duesseldorf, University Hospital, Duesseldorf, Germany.
Department of Anesthesiology, Heinrich Heine University Duesseldorf, University Hospital, Duesseldorf, Germany.

A Gülay (A)

Department of Palliative Medicine, University Hospital Bonn, Bonn, Germany.

K Maus (K)

Department of Palliative Medicine, University Hospital Bonn, Bonn, Germany.

B Jaspers (B)

Department of Palliative Medicine, University Hospital Bonn, Bonn, Germany.

L Radbruch (L)

Department of Palliative Medicine, University Hospital Bonn, Bonn, Germany.

M Heckel (M)

Department of Palliative Medicine, Comprehensive Cancer Center, CCC Erlangen - EMN, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), University Hospital Erlangen, Erlangen, Germany.

I Klinger (I)

Department of Palliative Medicine, Comprehensive Cancer Center, CCC Erlangen - EMN, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), University Hospital Erlangen, Erlangen, Germany.

C Ostgathe (C)

Department of Palliative Medicine, Comprehensive Cancer Center, CCC Erlangen - EMN, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), University Hospital Erlangen, Erlangen, Germany.

U Kriesen (U)

Department of Medicine, Clinic III-Hematology, Oncology, Palliative Medicine - CCC Mecklenburg-Vorpommern, Rostock University Medical Center, Rostock, Germany.

C Junghanß (C)

Department of Medicine, Clinic III-Hematology, Oncology, Palliative Medicine - CCC Mecklenburg-Vorpommern, Rostock University Medical Center, Rostock, Germany.

E Lehmann (E)

Department of Palliative Medicine, Ludwig-Maximilians-University Munich, Munich University Hospital, Munich, Germany.

D Gesell (D)

Department of Palliative Medicine, Ludwig-Maximilians-University Munich, Munich University Hospital, Munich, Germany.

S Gauder (S)

Department of Palliative Medicine, Ludwig-Maximilians-University Munich, Munich University Hospital, Munich, Germany.

C Boehlke (C)

Faculty of Medicine, Medical Center, Department of Palliative Medicine, University of Freiburg, Freiburg, Germany.

G Becker (G)

Faculty of Medicine, Medical Center, Department of Palliative Medicine, University of Freiburg, Freiburg, Germany.

A Pralong (A)

Department of Palliative Medicine, University of Cologne, Faculty of Medicine and University Hospital, Cologne, Germany.

J Strupp (J)

Department of Palliative Medicine, University of Cologne, Faculty of Medicine and University Hospital, Cologne, Germany.

C Leisse (C)

Faculty of Medicine and University Hospital, Department I of Internal Medicine, University of Cologne, Cologne, Germany.

K Schloesser (K)

Department of Palliative Medicine, University of Cologne, Faculty of Medicine and University Hospital, Cologne, Germany.

R Voltz (R)

Department of Palliative Medicine, University of Cologne, Faculty of Medicine and University Hospital, Cologne, Germany.
Faculty of Medicine and University Hospital, Center for Integrated Oncology Aachen Bonn Cologne Dusseldorf (CIO ABCD), University of Cologne, Cologne, Germany.
Faculty of Medicine and University Hospital, Clinical Trials Center (ZKS), University of Cologne, Cologne, Germany.
Faculty of Medicine and University Hospital, Center for Health Services Research, University of Cologne, Cologne, Germany.

N Jung (N)

Faculty of Medicine and University Hospital, Department I of Internal Medicine, University of Cologne, Cologne, Germany.

S T Simon (ST)

Department of Palliative Medicine, University of Cologne, Faculty of Medicine and University Hospital, Cologne, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH